EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Editorial: Insights into targeting nanomaterials for drug delivery

Mandeep Kaur Marwah

British Journal of Biomedical Science · 20.11.2026 · 83

DOI: 10.3389/bjbs.2026.18080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Biomedical Science, online erschienen am 20.11.2026. Verfasst von Mandeep Kaur Marwah. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maan et al. review carbon quantum dots, fluorescent carbon nanoparticles typically below 10 nm, with applications ranging from bioimaging and biosensing to antimicrobial therapy and delivery across the blood-brain barrier. Their central argument is that biological behaviour, including subcellular localisation, is governed less by the carbon core than by precursor choice and synthesis-driven surface chemistry. The review is candid about the obstacles to translation: batch-to-batch variability, incomplete longterm toxicity and biodistribution data, the absence of standardised characterisation, and a regulatory landscape in which such materials are still assessed case by case.Three original articles then examine mesoporous silica from a formulation perspective. Al Tahan et al. loaded octreotide and bovine serum albumin into a commercial silica microparticle, SYLOID, with a view to oral protein delivery. An oral protein is degraded by gastric acid and intestinal enzymes before it reaches its site of action; silica only protects what is within the pores, rather than adsorbed on the surface. Loading was governed by diffusion and was therefore sensitive to protein size and solvent viscosity. Octreotide, a 1 kDa peptide, reached a recovery of 71% when loaded from methanol and was distributed evenly through the particle. Albumin, at 68 kDa, reached at most 32% from water, aggregated in alcohols and remained largely at the particle surface.Al Nuss et al. compared three amorphisation strategies for cefdinir, a poorly soluble and poorly permeable antibiotic: a polymeric solid dispersion, a mesoporous silica system and a co-amorphous formulation with amino acids. For such a drug the first barrier to any targeted effect is getting into solution, and staying that way on the shelf. Hansen solubility parameters and Flory-Huggins theory guided excipient selection. The solid dispersion and co-amorphous systems gave the fastest dissolution and best maintained supersaturation, yet under accelerated humid storage they recrystallised and lost roughly half their drug content within six months. The silica formulation dissolved more slowly but retained over 95% of its drug content and remained amorphous under all storage conditions, attributed to confinement of the drug within the pores and the absence of hygroscopic excipients.Al Tahan, Russell and Al-Khattawi confronted a problem rarely reported: mesoporous silica microparticles do not compress well. This matters for targeting a carrier engineered to hold and protect a drug is of little use if tabletting collapses and releases drug prematurely. SYLOID alone fragmented under pressure rather than forming tablets, with mean particle size falling from 117 to 35µm. As silica content increased, tablet porosity rose but tensile strength fell and disintegration slowed. Adjusting the ratio of microcrystalline cellulose to lactose helped, but only the addition of a binder and a superdisintegrant brought a silica tablet within pharmacopoeial limits for both friability and disintegration. Drug-loaded tablets are the next step.The final article moves from oral to topical delivery. Marwah et al. formulated withaferin A, a poorly soluble anti-inflammatory steroidal lactone from Withania somnifera, into liposomes of around 120nm incorporated into hydroxypropyl methylcellulose gels. Withaferin A is of interest as an alternative to topical corticosteroids, whose long-term use thins the skin, but its poor solubility and skin permeability limit topical use. The formulation addresses this in two stages: liposomes, made more deformable with Tween-20, are intended to carry the hydrophobic drug across the stratum corneum, and the gel then retains the liposomes at the site and slows release. The liposomal gel released the drug more slowly than either solution or plain gel. In endothelial cells and dermal fibroblasts stimulated with TNF-α, the formulation reduced IL-6 secretion and intracellular reactive oxygen species, and lowered MMP-9 secretion by fibroblasts. Ex vivo permeation and retention studies are the next step.Together, these papers share a recurring lesson: performance is rarely a property of the carrier alone. It includes design decisions such as surface chemistry, loading solvent, stabilising excipient and diluent ratio, and it almost always involves trade-offs. The cefdinir formulations that dissolved fastest were the least stable. Silica content that raised tablet porosity also weakened the tablet. The most elaborate functionalisation strategies are the hardest to reproduce. Recognising these trade-offs early, and using predictive tools such as solubility parameter modelling to navigate them, may matter as much to translation as any new material.The collection also shows where the field must go next. The original studies here are in vitro, and much of the wider literature is too. Loaded carriers need to be evaluated for release and permeation in biorelevant and ex vivo models, and targeting claims confirmed in vivo. Long-term safety data are needed, particularly for newer materials. I hope this Special Issue encourages work that treats manufacturability, stability and safety not as afterthoughts but as part of the design of targeted delivery systems from the outset.This editorial was written by the Special Issue guest editor, MKM.

Zitieren

APA

Marwah, M. K. (2026). Editorial: Insights into targeting nanomaterials for drug delivery. British Journal of Biomedical Science, 83. https://doi.org/10.3389/bjbs.2026.18080

Vancouver

Marwah MK. Editorial: Insights into targeting nanomaterials for drug delivery. British Journal of Biomedical Science. 2026;83. doi:10.3389/bjbs.2026.18080

BibTeX
@article{Marwah2026,
  author = {Marwah, Mandeep Kaur},
  title = {Editorial: Insights into targeting nanomaterials for drug delivery},
  journal = {British Journal of Biomedical Science},
  year = {2026},
  volume = {83},
  doi = {10.3389/bjbs.2026.18080}
}
Kostenlos starten →